Clinical Research Directory
Browse clinical research sites, groups, and studies.
Botulinum Toxin Therapy in Hidradenitis Suppurativa
Sponsor: University of Massachusetts, Worcester
Summary
This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.
Official title: Targeting Nociceptors in Hidradenitis Suppurativa
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2022-06-07
Completion Date
2028-04-30
Last Updated
2025-09-15
Healthy Volunteers
No
Conditions
Interventions
Botulinum toxin
Administration of botulinum toxin (50 units/100cm2 injected intradermally) into lesional skin
Locations (1)
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States